Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
15M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
5.72M
-
Shares change
-
-638K
-
Total reported value, excl. options
-
$34.2M
-
Value change
-
-$3.79M
-
Number of buys
-
17
-
Number of sells
-
-11
-
Price
-
$5.98
Significant Holders of CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) as of Q4 2014
44 filings reported holding CPIX - CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value as of Q4 2014.
CUMBERLAND PHARMACEUTICALS INC - Common Stock, no par value (CPIX) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.72M shares
of 15M outstanding shares and own 38.2% of the company stock.
Largest 10 shareholders include ARIEL INVESTMENTS, LLC (2.09M shares), DIMENSIONAL FUND ADVISORS LP (850K shares), MILLENNIUM MANAGEMENT LLC (643K shares), BlackRock Institutional Trust Company, N.A. (462K shares), VANGUARD GROUP INC (279K shares), NEW YORK STATE COMMON RETIREMENT FUND (240K shares), RENAISSANCE TECHNOLOGIES LLC (121K shares), GW HENSSLER & ASSOCIATES LTD (116K shares), BARD ASSOCIATES INC (88.7K shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (84K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.